Principal Scientist
Merck & Co. Inc.
West Point, Pennsylvania
Dr. Xuanwen (Shawn) Li is currently a principal scientist and scientific supervisor in the Analytical R&D, Mass Spectrometry group at Merck & Co.. His research focused on mass spectrometry-based biologics and vaccine characterization for CMC development and regulatory submission. Prior to join Merck in 2018, Dr. Li worked as a research scientist at Eli Lilly on protein characterization. Before his industry career, Dr. Li was a director of the mass spectrometry facility at the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania. Dr. Li received a Ph.D. in proteomics at the Hunan Normal University in China and completed his post-doctoral training in clinical pharmacology and bioanalysis at the University of Pennsylvania.
Disclosure information not submitted.
Measurement and Control of Host Cell Proteins for Biopharmaceutical Development
Wednesday, October 23, 2024
3:30 PM – 3:45 PM MT